Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2
The recent emergence of SARS-CoV-2 Omicron variants possessing large numbers of mutations has raised concerns of decreased effectiveness of current vaccines, therapeutic monoclonal antibodies, and antiviral drugs for COVID-19 against these variants1,2. While the original Omicron lineage, BA.1, has b...
Saved in:
Published in | Nature |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article Web Resource |
Language | English Japanese |
Published |
United States
Research Square
24.02.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The recent emergence of SARS-CoV-2 Omicron variants possessing large numbers of mutations has raised concerns of decreased effectiveness of current vaccines, therapeutic monoclonal antibodies, and antiviral drugs for COVID-19 against these variants1,2. While the original Omicron lineage, BA.1, has become dominant in many countries, BA.2 has been detected in at least 67 countries and has become dominant in the Philippines, India, and Denmark. Here, we evaluated the replicative ability and pathogenicity of an authentic infectious BA.2 isolate in immunocompetent and human ACE2 (hACE2)-expressing mice and hamsters. In contrast to recent data with chimeric, recombinant SARS-CoV-2 strains expressing the spike proteins of BA.1 and BA.2 on an ancestral WK-521 backbone3, we observed similar infectivity and pathogenicity in mice and hamsters between BA.2 and BA.1, and less pathogenicity compared to early SARS-CoV-2 strains. We also observed a marked and significant reduction in the neutralizing activity of plasma from COVID-19 convalescent individuals and vaccine recipients against BA.2 compared to ancestral and Delta variant strains. In addition, we found that some therapeutic monoclonal antibodies (REGN10987/REGN10933, COV2-2196/COV2-2130, and S309) and antiviral drugs (molnupiravir, nirmatrelvir, and S-217622) can restrict viral infection in the respiratory organs of hamsters infected with BA.2. These findings suggest that the replication and pathogenicity of BA.2 is comparable to that of BA.1 in rodents and that several therapeutic monoclonal antibodies and antiviral compounds are effective against Omicron/BA.2 variants. |
---|---|
AbstractList | The recent emergence of SARS-CoV-2 Omicron variants possessing large numbers of mutations has raised concerns of decreased effectiveness of current vaccines, therapeutic monoclonal antibodies, and antiviral drugs for COVID-19 against these variants1,2. While the original Omicron lineage, BA.1, has become dominant in many countries, BA.2 has been detected in at least 67 countries and has become dominant in the Philippines, India, and Denmark. Here, we evaluated the replicative ability and pathogenicity of an authentic infectious BA.2 isolate in immunocompetent and human ACE2 (hACE2)-expressing mice and hamsters. In contrast to recent data with chimeric, recombinant SARS-CoV-2 strains expressing the spike proteins of BA.1 and BA.2 on an ancestral WK-521 backbone3, we observed similar infectivity and pathogenicity in mice and hamsters between BA.2 and BA.1, and less pathogenicity compared to early SARS-CoV-2 strains. We also observed a marked and significant reduction in the neutralizing activity of plasma from COVID-19 convalescent individuals and vaccine recipients against BA.2 compared to ancestral and Delta variant strains. In addition, we found that some therapeutic monoclonal antibodies (REGN10987/REGN10933, COV2-2196/COV2-2130, and S309) and antiviral drugs (molnupiravir, nirmatrelvir, and S-217622) can restrict viral infection in the respiratory organs of hamsters infected with BA.2. These findings suggest that the replication and pathogenicity of BA.2 is comparable to that of BA.1 in rodents and that several therapeutic monoclonal antibodies and antiviral compounds are effective against Omicron/BA.2 variants. |
Author | Koga, Michiko Mitamura, Keiko Godbole, Sucheta Uraki, Ryuta Hattori, Shin-Ichiro Adachi, Eisuke Wright, Ryan Saito, Makoto Yamayoshi, Seiya Ueki, Hiroshi Iida, Shun Furusawa, Yuri Liu, Yanan Yamamoto, Shinya Imai, Masaki Halfmann, Peter Duong, Calvin Kuroda, Makoto Murakami, Jurika Ujie, Michiko Yasuhara, Atsuhiro Fujisaki, Seiichiro Sakai, Yuko Ito, Mutsumi Takashita, Emi Yotsuyanagi, Hiroshi Hagihara, Masao Hojo, Masayuki Ohmagari, Norio Maeda, Kenji Sato, Tetsuro Matsubara, Shohei Chong, Zhenlu Diamond, Michael Loeber, Samantha Li, Rong Suzuki, Tadaki Watanabe, Shinji Okuda, Moe Iwatsuki-Horimoto, Kiyoko Mitsuya, Hiroaki Kiso, Maki Wang, Zhongde Tsutsumi, Takeya Kawaoka, Yoshihiro Ozono, Seiya Maemura, Tadashi Larson, Deanna Hasegawa, Hideki Douek, Daniel |
Author_xml | – sequence: 1 givenname: Yoshihiro orcidid: 0000-0001-5061-8296 surname: Kawaoka fullname: Kawaoka, Yoshihiro organization: University of Wisconsin-Madison – sequence: 2 givenname: Ryuta orcidid: 0000-0003-0890-1922 surname: Uraki fullname: Uraki, Ryuta organization: National Center for Global Health and Medicine Research Institute – sequence: 3 givenname: Maki surname: Kiso fullname: Kiso, Maki organization: Institute of Medical Sciences, University of Tokyo – sequence: 4 givenname: Shun orcidid: 0000-0003-2258-9031 surname: Iida fullname: Iida, Shun organization: National Institute of Infectious Diseases – sequence: 5 givenname: Masaki orcidid: 0000-0001-6988-1975 surname: Imai fullname: Imai, Masaki organization: University of Tokyo – sequence: 6 givenname: Emi orcidid: 0000-0002-9064-4699 surname: Takashita fullname: Takashita, Emi organization: National Institute of Infectious Diseases – sequence: 7 givenname: Makoto surname: Kuroda fullname: Kuroda, Makoto organization: University of Wisconsin at Madison – sequence: 8 givenname: Peter surname: Halfmann fullname: Halfmann, Peter organization: Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA – sequence: 9 givenname: Samantha surname: Loeber fullname: Loeber, Samantha organization: University of Wisconsin-Madison – sequence: 10 givenname: Tadashi surname: Maemura fullname: Maemura, Tadashi organization: University of Wisconsin – sequence: 11 givenname: Seiya orcidid: 0000-0001-7768-5157 surname: Yamayoshi fullname: Yamayoshi, Seiya organization: University Of Tokyo – sequence: 12 givenname: Seiichiro surname: Fujisaki fullname: Fujisaki, Seiichiro organization: National Institute of Infectious Diseases – sequence: 13 givenname: Zhongde orcidid: 0000-0003-2441-4729 surname: Wang fullname: Wang, Zhongde organization: Utah State University – sequence: 14 givenname: Mutsumi surname: Ito fullname: Ito, Mutsumi organization: University of Tokyo, Institute of Medical Science – sequence: 15 givenname: Michiko surname: Ujie fullname: Ujie, Michiko organization: Division of Virology, Institute of Medical Science, University of Tokyo – sequence: 16 givenname: Kiyoko orcidid: 0000-0002-8266-020X surname: Iwatsuki-Horimoto fullname: Iwatsuki-Horimoto, Kiyoko organization: University of Tokyo – sequence: 17 givenname: Yuri surname: Furusawa fullname: Furusawa, Yuri organization: Division of Virology, Institute of Medical Science, University of Tokyo – sequence: 18 givenname: Ryan surname: Wright fullname: Wright, Ryan organization: Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison – sequence: 19 givenname: Zhenlu surname: Chong fullname: Chong, Zhenlu organization: Washington University – sequence: 20 givenname: Seiya orcidid: 0000-0002-1764-2937 surname: Ozono fullname: Ozono, Seiya organization: National Institute of Infectious Diseases – sequence: 21 givenname: Atsuhiro surname: Yasuhara fullname: Yasuhara, Atsuhiro organization: Division of Virology, Institute of Medical Science, University of Tokyo – sequence: 22 givenname: Hiroshi orcidid: 0000-0002-6557-0771 surname: Ueki fullname: Ueki, Hiroshi organization: The University of Tokyo – sequence: 23 givenname: Yuko surname: Sakai fullname: Sakai, Yuko organization: Institute of Medical Sciences, University of Tokyo – sequence: 24 givenname: Rong surname: Li fullname: Li, Rong organization: Department of Animal Dairy, and Veterinary Sciences, College of Agriculture and Applied Sciences, Utah State University – sequence: 25 givenname: Yanan surname: Liu fullname: Liu, Yanan organization: Department of Animal Dairy, and Veterinary Sciences, College of Agriculture and Applied Sciences, Utah State University – sequence: 26 givenname: Deanna surname: Larson fullname: Larson, Deanna organization: Utah State University, College of Agriculture and Applied Sciences – sequence: 27 givenname: Michiko surname: Koga fullname: Koga, Michiko organization: The Institute of Medical Science, the University of Tokyo – sequence: 28 givenname: Takeya surname: Tsutsumi fullname: Tsutsumi, Takeya organization: Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo – sequence: 29 givenname: Eisuke orcidid: 0000-0002-1623-873X surname: Adachi fullname: Adachi, Eisuke organization: The Institute of Medical Science, the University of Tokyo – sequence: 30 givenname: Makoto surname: Saito fullname: Saito, Makoto organization: Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo – sequence: 31 givenname: Shinya surname: Yamamoto fullname: Yamamoto, Shinya organization: Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo – sequence: 32 givenname: Shohei surname: Matsubara fullname: Matsubara, Shohei organization: Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo – sequence: 33 givenname: Masao surname: Hagihara fullname: Hagihara, Masao organization: Division of Infection Control, Eiju General Hospital – sequence: 34 givenname: Keiko surname: Mitamura fullname: Mitamura, Keiko organization: Division of Infection Control, Eiju General Hospital – sequence: 35 givenname: Tetsuro surname: Sato fullname: Sato, Tetsuro organization: Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital – sequence: 36 givenname: Masayuki surname: Hojo fullname: Hojo, Masayuki organization: Department of Respiratory Medicine, National Center for Global Health and Medicine Hospital – sequence: 37 givenname: Shin-Ichiro orcidid: 0000-0002-5637-3397 surname: Hattori fullname: Hattori, Shin-Ichiro organization: National Center for Global Health and Medicine Research Institute – sequence: 38 givenname: Kenji orcidid: 0000-0002-9424-1491 surname: Maeda fullname: Maeda, Kenji organization: National Center For Global Health and Medicine – sequence: 39 givenname: Moe surname: Okuda fullname: Okuda, Moe organization: Department of Virology, Institute of Medical Science, University of Tokyo – sequence: 40 givenname: Jurika surname: Murakami fullname: Murakami, Jurika organization: Department of Virology, Institute of Medical Science, University of Tokyo – sequence: 41 givenname: Calvin surname: Duong fullname: Duong, Calvin organization: Department of Virology, Institute of Medical Science, University of Tokyo – sequence: 42 givenname: Sucheta surname: Godbole fullname: Godbole, Sucheta organization: Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health – sequence: 43 givenname: Daniel surname: Douek fullname: Douek, Daniel organization: NIH – sequence: 44 givenname: Shinji surname: Watanabe fullname: Watanabe, Shinji organization: National Institute of Infectious Diseases – sequence: 45 givenname: Norio surname: Ohmagari fullname: Ohmagari, Norio organization: Disease Control and Prevention Center, National Center for Global Health and Medicine – sequence: 46 givenname: Hiroshi surname: Yotsuyanagi fullname: Yotsuyanagi, Hiroshi organization: University of Tokyo – sequence: 47 givenname: Michael orcidid: 0000-0002-8791-3165 surname: Diamond fullname: Diamond, Michael organization: Washington University in Saint Louis – sequence: 48 givenname: Hideki surname: Hasegawa fullname: Hasegawa, Hideki organization: National Institute of Infectious Diseases – sequence: 49 givenname: Hiroaki orcidid: 0000-0001-9274-3853 surname: Mitsuya fullname: Mitsuya, Hiroaki organization: National Center for Global Health and Medicine Research Institute – sequence: 50 givenname: Tadaki orcidid: 0000-0002-3820-9542 surname: Suzuki fullname: Suzuki, Tadaki organization: National Institute of Infectious Diseases |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35233565$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j1FLwzAcxIMobs59AkEKPqdN_mmS5nEWdcJg4NTXkqYpZmzNTNrB_PQWnA_HvRz3u7tBl53vLEJ3lKRAgbAsxJSlIWLKJCeKZkd6gaYgFMOcUD5B8xhdTbgEJhWl12jCODDGBZ-iZfmlgza9De5H9853ie6aUb07uqB3SRyisYfe1W7n-lPi22SzeNvg0n9iSNZ7Z4LvssdFCrfoqtW7aOdnn6GP56f3colX65fXcrHCWxjhmIFRILQFQ3JtCqUL0-hWF0XNhR0nW5MXFgB4TqUgrWGFkLWi3AJr87zhbIYe_noPwX8PNvbV1g-hG5EVSCKYUpDLMXV_Tg313jbVIbi9Dqfq_zj7BYixWnY |
ContentType | Journal Article Web Resource |
Copyright | 2022. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2022. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | NPM 3V. 7XB 88I 8FK AAFGM ABUWG ADZZV AFKRA AFLLJ AFOLM AGAJT AQTIP AZQEC BENPR CCPQU COVID DWQXO GNUQQ HCIFZ M2P PHGZM PHGZT PIMPY PKEHL PQCXX PQEST PQQKQ PQUKI PRINS Q9U |
DOI | 10.21203/rs.3.rs-1375091/v1 |
DatabaseName | PubMed ProQuest Central (Corporate) ProQuest Central (purchase pre-March 2016) Science Database (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central Korea - hybrid linking ProQuest Central (Alumni) ProQuest Central (Alumni) - hybrid linking ProQuest Central UK/Ireland SciTech Premium Collection - hybrid linking ProQuest Central Student - hybrid linking ProQuest Central Essentials - hybrid linking ProQuest Women's & Gender Studies - hybrid linking ProQuest Central Essentials ProQuest Central ProQuest One Community College Coronavirus Research Database ProQuest Central Korea ProQuest Central Student SciTech Premium Collection Science Database ProQuest Central Premium ProQuest One Academic ProQuest Publicly Available Content ProQuest One Academic Middle East (New) ProQuest Central - hybrid linking ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic |
DatabaseTitle | PubMed Publicly Available Content Database ProQuest Science Journals (Alumni Edition) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Basic ProQuest Central Essentials ProQuest Science Journals ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Central China ProQuest Central ProQuest One Academic UKI Edition ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) |
DatabaseTitleList | Publicly Available Content Database PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2693-5015 |
ExternalDocumentID | 35233565 |
Genre | Preprint |
GroupedDBID | NPM 3V. 7XB 88I 8FK ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO GNUQQ HCIFZ M2P PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS Q9U |
ID | FETCH-LOGICAL-j2791-32c926ae2c04ac89a8cdafa88b56e269ec48e222541760fc3867b915e23f44d53 |
IEDL.DBID | BENPR |
IngestDate | Mon Jun 30 04:24:39 EDT 2025 Wed Feb 19 02:07:57 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Japanese |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-j2791-32c926ae2c04ac89a8cdafa88b56e269ec48e222541760fc3867b915e23f44d53 |
Notes | ObjectType-Article-1 content type line 62 ObjectType-Feature-2 SourceType-Undefined-1 |
ORCID | 0000-0002-9064-4699 0000-0003-2441-4729 0000-0002-5637-3397 0000-0001-7768-5157 0000-0001-6988-1975 0000-0003-0890-1922 0000-0001-9274-3853 0000-0003-2258-9031 0000-0001-5061-8296 0000-0002-1764-2937 0000-0002-3820-9542 0000-0002-8791-3165 0000-0002-1623-873X 0000-0002-8266-020X 0000-0002-9424-1491 0000-0002-6557-0771 |
OpenAccessLink | https://www.proquest.com/docview/2706399247?pq-origsite=%requestingapplication% |
PMID | 35233565 |
PQID | 2706399247 |
PQPubID | 4965281 |
ParticipantIDs | proquest_journals_2706399247 pubmed_primary_35233565 |
PublicationCentury | 2000 |
PublicationDate | 2022-Feb-24 20220224 |
PublicationDateYYYYMMDD | 2022-02-24 |
PublicationDate_xml | – month: 02 year: 2022 text: 2022-Feb-24 day: 24 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Durham |
PublicationTitle | Nature |
PublicationTitleAlternate | Res Sq |
PublicationYear | 2022 |
Publisher | Research Square |
Publisher_xml | – name: Research Square |
References | 35576972 - Nature. 2022 Jul;607(7917):119-127. doi: 10.1038/s41586-022-04856-1 |
References_xml | – reference: 35576972 - Nature. 2022 Jul;607(7917):119-127. doi: 10.1038/s41586-022-04856-1 |
SSID | ssib057237911 |
Score | 1.7888892 |
SecondaryResourceType | preprint |
Snippet | The recent emergence of SARS-CoV-2 Omicron variants possessing large numbers of mutations has raised concerns of decreased effectiveness of current vaccines,... |
SourceID | proquest pubmed |
SourceType | Aggregation Database Index Database |
SubjectTerms | Coronaviruses COVID-19 Monoclonal antibodies Severe acute respiratory syndrome coronavirus 2 |
Title | Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35233565 https://www.proquest.com/docview/2706399247 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFG8ELsaLxi8UyQ5ey7a268fJAIEQE5CAKLel67qDkQ03MPG_t92GnvTQy0vaw2v7fq-v7_0eAPdJFAdCsQAm1MOQaI6hND4cNHfSIIJmCSrZ9qczOlmRx3WwrgNuRZ1WebCJpaGOM2Vj5C5iJZgiwh62H9B2jbK_q3ULjQZoGRPMeRO0BqPZfFHRCxmRh9286OFeXkAfl-Dofvp_O5MlqIxPwcmrjpxD_PwMHOn0HEyGPwzKVYGkY576ZtgmD7l8d4p9USailDmtX06WOMv-YgmH2QtEztPGptel7qDfQxdgNR49Dyew7nYA3xATPsRICUSlRsojUnEhuYplIjmPAqoRFVoRru3rjPiMeonCnLJI-IFGOCEkDvAlaKZZqq-BI6QXoIjq2CMxEZSZRaliGsecCiNjbdA5KCCsj2wR_iq4Da4qpYTbivEiNF4axsb1u_l_4i04RrY6wFZ8kw5o7vK9vjOYvYu69cZ0QWM2n34DAMWYCg |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV09T8MwELWqMoBYQHwVCmSA0U1iO3Y8IEQLqAVaUD-gW3AcZ0CQQkJB_VP8RuykgQm2DlksxcOdfe_ZvrsHwFEcRh6XzIMxdTAkysdQaA4H9Z7UiKBYjPJu-90ebY_I1dgbV8BXWQtj0irLmJgH6mgizR25jVgOpoiw09c3aFSjzOtqKaFRLItrNfvUR7bspHOu_XuM0OXFsNWGc1UB-IQYdyFGkiMqFJIOEdLnwpeRiIXvhx5ViHIlia_MKYi4jDqxxD5lIXc9hXBMSGRUInTIXyKYOqgKlpoXvbt-0c5Io4CD7TRr4EaaQRfnYGx_uH-T1xzELtfA6oMKrfK-fh1UVLIB2q2fjs1FQaYlkkh_RlQiFc9WNs3yxJc8h3ZmTWJrcNYfwNbkHiLr9sWk8yV286yBNsFoIXbYAtVkkqgdYHHheCikKnJIRDhlelIqmcKRT7keYzVQLw0QzLdIFvw6tAa2C6MEr0WHjUCzQow11dz9_8dDsNwedm-Cm07veg-sIFOZYKrNSR1U39Op2td84T08mDvJAo-LXhff3UHS7Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+and+antiviral+susceptibility+of+SARS-CoV-2+Omicron%2FBA.2&rft.jtitle=Nature&rft.au=Kawaoka%2C+Yoshihiro&rft.au=Uraki%2C+Ryuta&rft.au=Kiso%2C+Maki&rft.au=Iida%2C+Shun&rft.date=2022-02-24&rft.pub=Research+Square&rft_id=info:doi/10.21203%2Frs.3.rs-1375091%2Fv1 |